+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
MALE
ID07802704

Evaluating the Safety and Effectiveness of Risvutatug Rezetecan Compared to Standard Hormone Therapies in Men With Metastatic Castration-Resistant Prostate Cancer

Led by GlaxoSmithKline · Updated on 2026-10-02

684

Participants Needed

6

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating risvutatug rezetecan Ris-Rez in men with metastatic castration-resistant prostate cancer mCRPC to see how well it works compared to the best supportive or standard care, which may include hormone therapy with androgen receptor pathway inhibitors ARPI. The study aims to determine if Ris-Rez can shrink or eliminate tumors, improve survival, and enhance quality of life. It also assesses the safety and tolerability of Ris-Rez and seeks to better understand its side effects. Participants are randomly assigned to receive either Ris-Rez or physicians choice of best supportivestandard care, which may include ARPI drugs such as Enzalutamide or Abiraterone combined with Prednisone or Prednisolone. The study is conducted in a parallel design and monitors participants over a period of up to approximately 169 weeks to evaluate treatment effects. During the study, participants undergo regular assessments including radiographic scans to measure disease progression and survival, evaluations of pain progression, tumor response, prostate-specific antigen levels, and skeletal events. Safety is closely monitored by tracking adverse events and immune responses to Ris-Rez. Participants experiences with the study treatment are also collected. The total participation may last over three years, with ongoing evaluations throughout this time.

CONDITIONS

Brief Title

A Study of Risvutatug Rezetecan in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) [EMBOLD Prostate-302]

Research Team

U

US GSK Clinical Trials Call Center

E

EU GSK Clinical Trials Call Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here